Caris Life Sciences, Inc.

CAI·NASDAQ·$15.52Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202503/03/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report09/14/26 8-KCurrent report08/05/26 8-KCurrent report06/05/26 8-KCurrent report05/07/26 8-KCurrent report04/02/26

Prospectuses and Registrations

424B4Prospectus06/20/25 S-8Registration of securities for employees06/18/25 S-1/ARegistration statement (amended)06/16/25 S-1/ARegistration statement (amended)06/09/25 S-1Registration statement (IPO)05/23/25

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26

Ownership

Form 4Insider transaction09/23/26 144Proposed sale of securities09/22/26 144Proposed sale of securities09/17/26 Form 4Insider transaction09/17/26 144Proposed sale of securities09/04/26

Other

8-A12B8-A12B06/16/26 CERTCEO/CFO certification06/16/26 ARSAnnual report to shareholders04/23/26 CERTCEO/CFO certification06/17/25 EFFECTRequest for effectiveness06/17/25